Placeholder

A Fair Environment Australia Advances

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

SKU: 2489. Category: .

Product Description

With its stable socio-political environment, strong intellectual property laws, and established links to the Asia-Pacific region, Australia enjoys some significant global and regional advantages. Despite its relatively small population, a Pharmaceuticals Industry Strategy Group report shows Australia has a healthy number of pharmaceutical companies, including more than 40 originator companies (predominantly subsidiaries of multinational companies), around 10 generic companies, 470 small-scale core biotechnology companies, and more than 20 world-class medical…

Sidebars:
Current Clinical Trial Activity in Australia
An Industry Perspective on Australia’s Reimbursement Program

Experts
Graham Edwards
. Managing Director, Ogilvy Healthworld ­Sydney, a part Ogilvy ­CommonHealth Worldwide, the health behavior experts of Ogilvy & Mather (ogilvy.com), representing one of the largest assemblies of creative talent in the world of healthcare communications with 66 offices across 36 countries. For more ­information, visit ogilvychww.com.
Terry Hisey. Vice Chairman and U.S. Life ­Sciences Leader, Deloitte, part of a global ­network of member firms in more than 150 countries that provides audit, tax, ­consulting, and ­financial advisory services to public and ­private clients spanning multiple industries. For more information, visit, ­deloitte.com.
Ash Kuchel. President Asia ­Pacific, Publicis Healthcare ­Communications Group, a ­healthcare communications ­network and a division of Publicis Groupe S.A. For more ­information, visit ­publicishealthcare.com.
Brendan Shaw, Ph.D. Chief ­Executive, ­Medicines ­Australia, which represents the ­discovery-driven pharmaceutical industry in Australia. For more information, visit ­medicinesaustralia.com.au.
Nick Ward. Principal Consultant, Pharma to Market, an Australia-based consulting ­company ­providing global ­regulatory ­support services and outsourcing solutions to the pharmaceutical industry. For more ­information, visit ­pharmatomarket.com.

FEEDBACK